References
- American Chemical Society. (2016). Naloxone. In: Molecule of the week archive. https://www.acs.org/content/acs/en/molecule-of-the-week/archive/n/naloxone.html
- Behar, E., Santos, G., Wheeler, E., Rowe, C., & Coffin, P. (2015). Brief overdose education is sufficient for naloxone distribution to opioid users. Drug and Alcohol Dependence, 148, 209–212. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2014.12.009
- Buchman, D. Z., Orkin, A. M., Strike, C., & Upshur, R. E. G. (2018). Overdose education and naloxone distribution programmes and the ethics of task shifting. Public Health Ethics, 11(2), 151–164. https://doi.org/https://doi.org/10.1093/phe/phy001
- Dettmer, K., Saunders, B., & Strang, J. (2001). Take home naloxone and the prevention of deaths from opiate overdose: Two pilot schemes. BMJ, 322(7291), 895–896. https://doi.org/https://doi.org/10.1136/bmj.322.7291.895
- Duff, C. (2015). Governing drug use otherwise: For an ethics of care. Journal of Sociology, 51(1), 81–96. https://doi.org/https://doi.org/10.1177/1440783314562502
- Farrugia, A., Fraser, S., & Dwyer, R. (2017). Assembling the social and political dimensions of take-home naloxone. Contemporary Drug Problems, 44(3), 163–175. https://doi.org/https://doi.org/10.1177/0091450917723350
- Farrugia, A., Fraser, S., Dwyer, R., Fomiatti, R., Neale, J., Dietze, P., & Strang, J. (2019). Take-home naloxone and the politics of care. Sociology of Health & Illness, 41(2), 427–443. https://doi.org/https://doi.org/10.1111/1467-9566.12848
- Farrugia, A., Neale, J., Dwyer, R., Fomiatti, R., Fraser, S., Strang, J., & Dietze, P. (2020). Conflict and communication: Managing the multiple affordances of take-home naloxone administration events in Australia. Addiction Research & Theory, 28(1), 29–37. https://doi.org/https://doi.org/10.1080/16066359.2019.1571193
- Faul, M., Lurie, P., Kinsman, J. M., Michael, D. W., Crabaugh, C., & Sasser, S. M. (2017). Multiple naloxone administrations among emergency medical service providers is increasing. Prehospital Emergency Care, 21(4), 411–419. https://doi.org/https://doi.org/10.1080/10903127.2017.1315203
- Faulkner-Gurstein, R. (2017). The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy. Social Science and Medicine, 110, 20–27. https://doi.org/https://doi.org/10.1016/j.socscimed.2017.03.013
- Frank, D., Mateu-Gelabert, P., Guarino, H., Bennett, A., Wendel, T., Jessell, L., & Teper, A. (2015). High risk and little knowledge: Overdose experiences and knowledge among young adult nonmedical prescription opioid users. The International Journal on Drug Policy, 26(1), 84–91. https://doi.org/https://doi.org/10.1016/j.drugpo.2014.07.013
- Fraser, S., Pienaar, K., Dilkes-Frayne, E., Moore, D., Kokanovic, R., Treloar, C., & Dunlop, A. (2017). Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis. The International Journal on Drug Policy, 44, 192–201. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.02.005
- Freeman, P. R., Hankosky, E. R., Lofwall, M. R., & Talbert, J. C. (2018). The changing landscape of naloxone availability in the United States, 2011–2017. Drug and Alcohol Dependence, 191, 361–364. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.07.017
- Giglio, R. E., Li, G., & DiMaggio, C. J. (2015). Effectiveness of bystander naloxone administration and overdose education programs: A meta-analysis. Injury Epidemiology, 2(1), 10. https://doi.org/https://doi.org/10.1186/s40621-015-0041-8
- Gowan, T., Whetstone, S., & Andic, T. (2012). Addiction, agency, and the politics of self-control: Doing harm reduction in a heroin users’ group. Social Science & Medicine, 74(8), 1251–1260. https://doi.org/https://doi.org/10.1016/j.socscimed.2011.11.045
- Green, T., Heimer, R., & Grau, L. E. (2008). Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of six overdose training and naloxone distribution programs in the United States. Addiction, 103(6), 979–989. https://doi.org/https://doi.org/10.1111/j.1360-0443.2008.02182.x
- Jasinski, D. R., Martin, W. R., & Haertzen, C. A. (1967). The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). The Journal of Pharmacology and Experimental Therapeutics, 157(2), 420–426.
- Jones, M. R., Viswanath, O., Peck, J., Kaye, A., Gill, J., & Simopoulos, T. (2018). A brief history of the opioid epidemic and strategies for pain medicine. Pain and Therapy, 7(1), 13–21. https://doi.org/https://doi.org/10.1007/s40122-018-0097-6
- Kerr, D., Paul, D., Kelly, A.-M., & Jolley, D. (2008). Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: Perspectives on intranasal administration. Journal of Urban Health, 85(3), 352–360. https://doi.org/https://doi.org/10.1007/s11524-008-9273-z
- Kim, H. K., Connors, N. J., & Mazer-Amirshahi, M. E. (2019). The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs. Expert Opinion on Drug Safety, 18(6), 465–475. https://doi.org/https://doi.org/10.1080/14740338.2019.1613372
- Kolla, G., & Strike, C. (2020). Practices of care among people who buy, use, and sell drugs in community settings. Harm Reduction Journal, 17(1), 27. https://doi.org/https://doi.org/10.1186/s12954-020-00372-5
- Lambdin, B. H., Bluthenthal, R. N., Wenger, L. D., Wheeler, E., Garner, B., Lakosky, P., & Kral, A. H. (2020). Overdose education and naloxone distribution within syringe service programs – United States, 2019. MMWR. Morbidity and Mortality Weekly Report, 69(33), 1117–1121. https://doi.org/https://doi.org/10.15585/mmwr.mm6933a2
- Lankenau, S. E., Wagner, K. D., Silva, K., Kecojevic, A., Iverson, E., McNeely, M., & Kral, A. H. (2013). Injection drug users trained by overdose prevention programs: Responses to witnessed overdoses. Journal of Community Health, 38(1), 133–141. https://doi.org/https://doi.org/10.1007/s10900-012-9591-7
- Leppo, A., & Perala, R. (2017). Remains of care: opioid substitution treatment in the post-welfare state. Sociology of Health & Illness, 39(6), 959–978. https://doi.org/https://doi.org/10.1111/1467-9566.12550
- Marshall, C., Piat, M., & Perreault, M. (2018). Exploring the psychological benefits and challenges experienced by peer-helpers participating in take-home naloxone programmes: A rapid review. Drugs, 25(3), 280–291. https://doi.org/https://doi.org/10.1080/09687637.2016.1269724 https://doi.org/https://doi.org/10.1080/09687637.2016.1269724
- McAuley, A., Munro, A., & Taylor, A. (2018). Once I’d done it once it was like writing your name: Lived experience of take-home naloxone administration by people who inject drugs. International Journal of Drug Policy, 58, 46–54. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.05.002
- McDonald, R., & Strang, J. (2016). Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction, 111(7), 1177–1187. https://doi.org/https://doi.org/10.1111/add.13326
- National Institute on Drug Abuse (NIDA). (2019). Opioid overdose crisis. In: Drugs of Abuse. National Institute of Health. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis
- Naumann, R., Durrance, C. P., Ranapurwala, S., Austin, A. E., Proescholdbell, S., Childs, R., Marshall, S. W., Kansagra, S., & Shanahan, M. E. (2019). Impact of a community-based naloxone distribution program on opioid overdose death rates. Drug and Alcohol Dependence, 204, 107536. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.06.038
- Neale, J., & Strang, J. (2015). Naloxone-does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose. Addiction, 110(10), 1644–1652. https://doi.org/https://doi.org/10.1111/add.13027
- Neale, J., Brown, C., Campbell, A., Jones, J. D., Metz, V., Strang, J., & Comer, S. (2019). How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies. Addiction, 114(4), 708–718. https://doi.org/https://doi.org/10.1111/add.14510
- Oregon Revised Statutes (ORS) 689.681: Opiate overdose (2020).
- Rees, D. I., Sabia, J. J., Argys, L. M., Dave, D., & Latshaw, J. (2019). With a little help from my friends: The effects of good Samaritan and naloxone access laws on opioid-related deaths. The Journal of Law and Economics, 62(1), 1–27. https://doi.org/https://doi.org/10.1086/700703
- Seal, K. H., Downing, M., Kral, A. H., Singleton-Banks, S., Hammond, J.-P., Lorvick, J., Ciccarone, D., & Edlin, B. R. (2003). Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: A survey of street-recruited injectors in the San Francisco Bay Area. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 80(2), 291–301. https://doi.org/https://doi.org/10.1093/jurban/jtg032
- Sondhi, A., Ryan, G., & Day, E. (2016). Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England. Harm Reduction Journal, 13, 5. https://doi.org/https://doi.org/10.1186/s12954-016-0094-1
- Strang, J., Powis, B., Best, D., Vingoe, L., Griffiths, P., Taylor, C., Welch, S., & Gossop, M. (1999). Preventing opiate overdose fatalities with take-home naloxone: Pre-launch study of possible impact and acceptability. Addiction, 94(2), 199–204. https://doi.org/https://doi.org/10.1046/j.1360-0443.1999.9421993.x
- Suzuki, J., & El-Haddad, S. (2017). A review: Fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend, 171, 107–116. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2016.11.033
- Wagner, K. D., Davidson, P. J., Iverson, E., Washburn, R., Burke, E., Kral, A. H., McNeeley, M., Jackson Bloom, J., & Lankenau, S. E. (2014). “I felt like a superhero”: the experience of responding to drug overdose among individuals trained in overdose prevention. The International journal on drug policy, 25(1), 157–165. https://doi.org/https://doi.org/10.1016/j.drugpo.2013.07.003
- Walley, A., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346, f174. https://doi.org/https://doi.org/10.1136/bmj.f174